Japan Animal Referral Medical Center Co., Ltd. (JP:6039) has released an update.
Japan Animal Referral Medical Center Co., Ltd. (JARMeC) reported a robust financial performance for the first quarter ended June 30, 2024, with operating profit and profit attributable to owners soaring by 296% and 471.8% respectively. The company’s net sales increased by 31.4%, and a forecast for the full year anticipates a continued positive trend with a 12.9% growth in net sales and a 30.5% increase in profit attributable to owners. Additionally, JARMeC is maintaining its shareholder rewards, projecting a year-end cash dividend of 25 yen per share.
For further insights into JP:6039 stock, check out TipRanks’ Stock Analysis page.
